Evidence map›Paper›PMID 28704432›Full record

ArticlePloS one2017

Determination of absolute expression profiles using multiplexed miRNA analysis.

Yunke Song, Duncan Kilburn, Jee Hoon Song, Yulan Cheng, Christopher T Saeui, Douglas G Cheung, Carlo M Croce, Kevin J Yarema, Stephen J Meltzer, Kelvin J Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yunke SongBiomedical Engineering Department, Johns Hopkins University, Baltimore, Maryland, United States of America.
Duncan KilburnCirculomics Inc, Baltimore, Maryland, United States of America.ORCID http://orcid.org/0000-0002-0772-7195
Jee Hoon SongDepartment of Medicine (GI Division) and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Yulan ChengDepartment of Medicine (GI Division) and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Christopher T SaeuiBiomedical Engineering Department, Johns Hopkins University, Baltimore, Maryland, United States of America.
Douglas G CheungDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio, United States of America.
Carlo M CroceDepartment of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio, United States of America.
Kevin J YaremaBiomedical Engineering Department, Johns Hopkins University, Baltimore, Maryland, United States of America.
Stephen J MeltzerDepartment of Medicine (GI Division) and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Kelvin J LiuCirculomics Inc, Baltimore, Maryland, United States of America.
Tza-Huei WangBiomedical Engineering Department, Johns Hopkins University, Baltimore, Maryland, United States of America.
Johns Hopkins University · USThe Ohio State University · USCirculomics (United States) · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
Facile screening for esophageal cancer in LMICsUH3CA211457 · NCI · JOHNS HOPKINS UNIVERSITY · PI MELTZER, STEPHEN J, WANG, TZA-HUEI JEFF · 2019 to 2021
$2.8M
(PQC-1) Driver Events In IBD-Associated Neoplastic ProgressionR01CA190040 · NCI · JOHNS HOPKINS UNIVERSITY · PI MELTZER, STEPHEN J, SELARU, FLORIN · 2014 to 2017
$2.5M
Cellular, molecular, and biochemical sciences training grantT32GM086252 · NIGMS · OHIO STATE UNIVERSITY · PI JACKMAN, JANE ELIZABETH, MUSIER-FORSYTH, KARIN M · 2011 to 2020
$2.0M
Ligo-miR - A Multiplex Assay Platform for Targeted miRNA ProfilingR44GM103360 · NIGMS · CIRCULOMICS, INC. · PI LIU, KELVIN, WANG, TZA-HUEI JEFF · 2015 to 2016
$1.5M
Facile screening for esophageal cancer in LMICsUG3CA211457 · NCI · JOHNS HOPKINS UNIVERSITY · PI MELTZER, STEPHEN J, WANG, TZA-HUEI JEFF · 2017 to 2018
$861k
Digital Detection of Tumor-Derived Circulating Methylated DNAR21CA186809 · NCI · JOHNS HOPKINS UNIVERSITY · PI WANG, TZA-HUEI JEFF · 2014 to 2016
$698k
PCR-free Multiplexed Detection of Circulating miRNA in BloodR21CA173390 · NCI · JOHNS HOPKINS UNIVERSITY · PI WANG, TZA-HUEI JEFF · 2012 to 2014
$676k
A Systems Biology Approach for Targeted Drug Discovery for LeishmaniasisR21AI127582 · NIAID · OHIO STATE UNIVERSITY · PI IBBA, MICHAEL, SATOSKAR, ABHAY R · 2017 to 2018
$401k
Ligo-miR - A Multiplexed Single Molecule Ligation Assay for miRNA ProfilingR43GM103360 · NIGMS · CIRCULOMICS, INC. · PI LIU, KELVIN, WANG, TZA-HUEI JEFF · 2012 to 2013
$400k
AGX1/2 inhibitors as key modulators of the hexosamine biosynthetic pathwayR21CA191715 · NCI · JOHNS HOPKINS UNIVERSITY · PI YAREMA, KEVIN J · 2015 to 2016
$388k
Inhibiting UAP1/2 as a Novel Strategy for Regulating Carbohydrate Metabolic FluxF31CA192767 · NCI · JOHNS HOPKINS UNIVERSITY · PI SAEUI, CHRISTOPHER · 2015 to 2016
$87k
NCI NIH HHS F31 CA192767NCI NIH HHS P30 CA006973NCI NIH HHS R01 CA190040NCI NIH HHS R21 CA173390NCI NIH HHS R21 CA186809NCI NIH HHS R21 CA191715NCI NIH HHS UG3 CA211457NCI NIH HHS UH3 CA211457NIAID NIH HHS R21 AI127582NIGMS NIH HHS R43 GM103360NIGMS NIH HHS R44 GM103360NIGMS NIH HHS T32 GM086252
6 · The paper itself

Abstract

Accurate measurement of miRNA expression is critical to understanding their role in gene expression as well as their application as disease biomarkers. Correct identification of changes in miRNA expression rests on reliable normalization to account for biological and technological variance between samples. Ligo-miR is a multiplex assay designed to rapidly measure absolute miRNA copy numbers, thus reducing dependence on biological controls. It uses a simple 2-step ligation process to generate length coded products that can be quantified using a variety of DNA sizing methods. We demonstrate Ligo-miR's ability to quantify miRNA expression down to 20 copies per cell sensitivity, accurately discriminate between closely related miRNA, and reliably measure differential changes as small as 1.2-fold. Then, benchmarking studies were performed to show the high correlation between Ligo-miR, microarray, and TaqMan qRT-PCR. Finally, Ligo-miR was used to determine copy number profiles in a number of breast, esophageal, and pancreatic cell lines and to demonstrate the utility of copy number analysis for providing layered insight into expression profile changes.

Indexed as

Cell Line, TumorDNA Copy Number VariationsGene Expression ProfilingHumansMCF-7 CellsMicroRNAsOligonucleotide Array Sequence AnalysisMicroRNAs

Identifiers

PMID28704432
PMCPMC5509254
OpenAlexW2735206325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.